Bertilimumab
Bertilimumab (CAT 213; iCo-008) is a human monoclonal antibody targeting eotaxin-1 (CCL11) . Bertilimumab has the potential for allergic disorders research[1].
Product Specifications
CAS Number
375348-49-5
Product Name Alternative
CAT 213; iCo-008
UNSPSC
12352203
Target
CCR
Type
Inhibitory Antibodies
Related Pathways
GPCR/G Protein; Immunology/Inflammation
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/bertilimumab.html
Purity
97.01
Solubility
10 mM in DMSO
Smiles
[Bertilimumab]
Molecular Weight
(144.18 kDa)
References & Citations
[1]Sarah Main, et al. A potent human anti-eotaxin1 antibody, CAT-213: isolation by phage display and in vitro and in vivo efficacy. J Pharmacol Exp Ther. 2006 Dec;319 (3) :1395-404.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 2
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
AE14031HU-01 48 Tests
Human Tumor necrosis factor alpha-induced protein 8-like protein 2 (TNFAIP8L2) ELISA Kit
Sign In for Pricing
View Details AE14031HU-02 96 Tests
Human Tumor necrosis factor alpha-induced protein 8-like protein 2 (TNFAIP8L2) ELISA Kit
Sign In for Pricing
View Details 
